Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03197038
Other study ID # 2016-1217
Secondary ID P30AG022849
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2017
Est. completion date December 18, 2019

Study information

Verified date June 2021
Source University of Illinois at Chicago
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic kidney disease (CKD), affects over 45% of all individuals over 70 years of age. Patients with moderate CKD have more than a two-fold increased risk of cognitive impairment than those without CKD; furthermore, as many as 20-70% of patients with CKD have established cognitive impairment and overt dementia. The burden of cognitive impairment and dementia leads to functional decline and accelerated loss of independence, contributing to the tremendous individual, societal, and economic burden of CKD (i.e., 20% of Medicare expenditures in adults >65 years of age). There is no recommended treatment to prevent cognitive decline in CKD patients, and the few medications available for cognitive impairment have only short term modest effects. There is a critical need to evaluate therapies to forestall cognitive impairment, and maintain or improve cognitive functioning in older patients with CKD. To address this need, this study will test the hypothesis that older patients with moderate/severe CKD and pre-clinical cognitive impairment randomized to a 6-month home-based exercise program will improve cognitive function and MRI measured brain structure, compared to a usual care control group. This study will combine an assessment of cognition with MR imaging techniques to fully evaluate brain structure, blood flow, and behavior relationships at a level previously not conducted in this population


Recruitment information / eligibility

Status Completed
Enrollment 39
Est. completion date December 18, 2019
Est. primary completion date November 26, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 80 Years
Eligibility Inclusion Criteria: - English speaking men and women - diagnosed stage 3-5 CKD (eGFR<60 to 15 ml/min); - 60-80 years of age, - self-experienced persistent decline in cognitive capacity determined as self-reported cognitive complaint (i.e., answering "yes" to the question: "Do you feel like your memory or thinking skills have gotten worse recently?" (before any clinical impairment of cognition has occurred) - ability to undergo an MRI; - no history of major head trauma. Exclusion Criteria: - • current/past diagnosis of neurological/psychiatric disorders; - any medications to improve cognition or mood; - Diagnosed Dementia or a score of <2 on the mini-cog assessment - Ischemic ulcerations or gangrene on the feet or legs; - Participating in a supervised exercise program with intent to increase fitness levels 3 days/week, - Requires assistive ambulation; - Limited exercise capacity due to conditions other than claudication - unstable angina, - Claudication - severe arthritis, - extreme dyspnea on exertion, - unstable coronary artery disease; - Class III-IV heart failure; - Current uncontrolled sustained arrhythmias, - severe/symptomatic aortic or mitral stenosis, - hypertrophic obstructive cardiomyopathy, - severe pulmonary hypertension, - active myocarditis/pericarditis, - thrombophlebitis, - recent systemic/pulmonary embolus (within 3 months); - Resting systolic BP >200 mmHg or resting diastolic BP >110 mmHg; - Revascularization procedures within the previous 6 months; - Any unforeseen illness or disability that would preclude exercise testing or training based on patient provider opinion; - Pregnancy - No diagnosis of CKD - One or more contraindication for MRI - cardiac pacemaker, - aneurysm clip, - cochlear implants, - shrapnel, - history of metal fragments in eyes, - neurostimulators, - diagnosed claustrophobia.

Study Design


Intervention

Behavioral:
Partially supervised home-based walking exercise
Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.
Control
Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.

Locations

Country Name City State
United States University of Illinois at Chicago Chicago Illinois

Sponsors (3)

Lead Sponsor Collaborator
University of Illinois at Chicago Midwest Roybal Center for Health Promotion and Translation, National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Composite Global Cognitive Function Determine the effect of a 6-month home-based exercise program on composite global cognitive functioning as determined by principal component analysis of immediate free recall of trials 1-5 on California verbal learning II, long-delay free recall and recognition, and memory discriminability, trail making test part A and part B, digit symbol substitution test, semantic and phonemic fluency, and Digit span subtest in older patients with kidney disease and preclinical cognitive impairment. A composite global cognitive score was created by converting the individual cognitive scores to standardized z scores and then averaging the standardized z scores. An increase in change from baseline to 6 months is considered an improvement. Change from baseline in composite global cognitive function at 6 months
Primary Composite Executive Function A composite executive functioning score was created by converting 4 individual executive cognitive scores (verbal fluency FAS and animal summary score, digit span backward subtest, and TMT-B) to standardized z scores and then averaging the standardized z scores. A larger change in Z score is considered an improvement. Change from baseline in composite executive function at 6 months
Secondary White Matter Integrity Whole brain white matter integrity was created by averaging the fractional anisotropy of 80 tracts using region of interest analysis. An increased change from baseline to 6 months in fractional anisotropy (a measure of directionality, 0 = no principle direction, 1 = one principle direction) is considered an improvement. Change from baseline white matter integrity fractional anisotropy at 6 months
Secondary Hippocampal Volume - Right Determine the effect of a 6-month exercise program on hippocampal volume. An increased change from baseline to 6 months in right hippocampal volume in cubic millimeters is considered an improvement. Change from baseline hippocampal volume at 6 months.
Secondary Cerebral Blood Flow Determine the effect of a 6-month exercise program on cerebral blood flow. Change in global cerebral blood measured in mL/100g/min from baseline to 6 months. An larger change is considered an improvement. Change from baseline in cerebral blood flow at 6 months.
Secondary Vascular Health - Young's Elastic Modulus Vascular health was assessed by Young's Elastic Modulus (YEM) at the carotid artery. A larger negative change in YEM (measured in kilo pascal, stiffer artery=higher number) from baseline to 6 months is considered an improvement. Change from baseline in vascular health indices at 6 months
Secondary Cognitive Function - Total Cognition Determine the effect of a 6-month exercise program on cognitive function via the NIH toolbox
This composite includes: Flanker, Dimensional Change Card Sort, Picture Sequence Memory, List Sorting and Pattern Comparison. This composite score is derived by averaging the standard scores of each of the measures, and then deriving standard scores based on this new distribution. An Age-Corrected Standard Score was used.
Scale runs 140 to 23, a higher score means a better outcome. An increased change from baseline to 6 months is considered an improvement
Mean change from baseline to 6 months.
Secondary Motor Function - Grip Strength Determine the effect of a 6-month exercise program on motor function via the NIH toolbox. Age corrected grip strength on a standard scale. Standard scale 140-23, higher score is better. An increased change from baseline to 6 months is considered an improvement. Change from baseline in NIH toolbox motor function indices at 6 months
Secondary Vascular Health - Pulse Wave Velocity Vascular function indices of vascular health was assessed using pulse wave velocity of the aorta in meters/second (higher number =more stiff aorta). A larger negative change from baseline to 6 months is considered an improvement. 6 Months
Secondary Vascular Health - Augmentation Index Vascular function indices of vascular health was assessed using augmentation index at the carotid artery (in percentage, higher percent=more stiff artery). A larger negative change from baseline to 6 months is considered an improvement. 6 Months
Secondary Cognitive Function - Fluid Cognition Determine the effect of a 6-month exercise program on cognitive function via the NIH toolbox. Fluid cognition.
This composite includes: Flanker, Dimensional Change Card Sort, Picture Sequence Memory, List Sorting and Pattern Comparison. This composite score is derived by averaging the standard scores of each of the measures, and then deriving standard scores based on this new distribution. An Age-Corrected Standard Score was used. A larger change from baseline to 6 months is considered an improvement.
Scale runs 140 to 23, a higher score means a better outcome.
Mean change from baseline to 6 months.
Secondary Cognitive Function - Crystalized Cognition Change from baseline in NIH toolbox cognitive function indices at 6 months. Crystalized cognition.
This composite includes : Flanker, Dimensional Change Card Sort, Picture Sequence Memory, List Sorting and Pattern Comparison. This composite score is derived by averaging the standard scores of each of the measures, and then deriving standard scores based on this new distribution. An Age-Corrected Standard Score was used.
An larger change from baseline to 6 months is considered an improvement. Scale runs 140 to 23, a higher score means a better outcome.
Mean change from baseline to 6 months.
Secondary Motor Function - Balance Determine the effect of a 6-month exercise program on motor function via the NIH toolbox. Change in balance age corrected standard score from baseline to 6-months (23-140, higher score is better). A larger change is considered an improvement. 6 Months
Secondary Motor Function - Dexterity Determine the effect of a 6-month exercise program on motor function via the NIH toolbox. Hand dexterity was determine using age corrected standard scale in the dominant hand. A larger change from baseline to 6 months is considered an improvement.
Standard scale range 140-23, higher score is better.
6 Months
Secondary Resting Global Connectivity Resting global connectivity measured and averaged across 132 regions. A larger change from baseline to 6 months is considered an improvement. Connectivity is a correlation (increased connectivity=higher correlation) Change from baseline at 6 months
Secondary Hippocampal Volume - Left Determine the effect of a 6-month exercise program on hippocampal volume. An larger change from baseline to 6 months in left hippocampal volume (cubic millimeters) is considered an improvement. Change from baseline at 6 Months
See also
  Status Clinical Trial Phase
Recruiting NCT06386172 - Electronic Decision-support System to Improve Detection and Care of Patients With Chronic Kidney Disease in Stockholm N/A
Recruiting NCT04910867 - APOL1 Genetic Testing Program for Living Donors N/A
Completed NCT03434145 - Changes of Ocular Structures After Hemodialysis in Patients With Chronic Kidney Diseases N/A
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Active, not recruiting NCT05887817 - Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Phase 4
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Terminated NCT05022329 - COVID-19 Vaccine Boosters in Patients With CKD Phase 2/Phase 3
Not yet recruiting NCT04925661 - HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia Phase 1
Recruiting NCT04961164 - Resistant Starch Prebiotic Effects in Chronic Kidney Disease N/A
Completed NCT05015647 - Low Protein Diet in CKD Patients at Risk of Malnutrition N/A
Completed NCT03426787 - Helping Empower Liver and Kidney Patients N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Completed NCT04363554 - The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease N/A
Recruiting NCT04831021 - Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role? N/A
Terminated NCT04877847 - Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury N/A
Recruiting NCT04422652 - Combination of Novel Therapies for CKD Comorbid Depression Phase 2
Completed NCT05055362 - Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study N/A
Not yet recruiting NCT06330480 - Check@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease N/A
Recruiting NCT03176862 - Left Ventricular Fibrosis in Chronic Kidney Disease N/A
Terminated NCT02539680 - Intestinal Phosphate Transporter Expression in CKD Patients N/A